Quarterly Transactions Made in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI). The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 9,148,078 | 9,107,572 | 18,255,650 | 9,152,908 | 1,089,373 | 10,242,281 | 8,013,369 | |
| Q1 2022 | 25,077,000 | 5,641,224 | 30,718,224 | 20,189,927 | 1,281,376 | 21,471,303 | 9,246,921 | |
| Q2 2022 | 18,132,175 | 9,520,590 | 27,652,765 | 15,561,645 | 4,290,761 | 19,852,406 | 7,800,359 | |
| Q3 2022 | 8,660,011 | 5,165,464 | 13,825,475 | 16,025,875 | 28,899 | 16,054,774 | -2,229,299 | |
| Q4 2022 | 14,996,398 | 9,494,260 | 24,490,658 | 9,270,522 | 10,841 | 9,281,363 | 15,209,295 | |
| Q1 2023 | 21,882,923 | 2,069,865 | 23,952,788 | 17,217,070 | 72 | 17,217,142 | 6,735,646 | |
| Q2 2023 | 16,355,065 | 2,135,854 | 18,490,919 | 16,287,852 | 0 | 16,287,852 | 2,203,067 | |
| Q3 2023 | 12,937,409 | 3,339,637 | 16,277,046 | 4,961,292 | 26,735 | 4,988,027 | 11,289,019 | |
| Q4 2023 | 10,029,250 | 10,027,037 | 20,056,287 | 34,179,523 | 72 | 34,179,595 | -14,123,308 | |
| Q1 2024 | 30,591,293 | 3,792,632 | 34,383,925 | 14,570,931 | 0 | 14,570,931 | 19,812,994 | |
| Q2 2024 | 13,104,566 | 1,947,554 | 15,052,120 | 14,620,673 | 161,891 | 14,782,564 | 269,556 | |
| Q3 2024 | 13,884,274 | 4,677,405 | 18,561,679 | 8,691,459 | 1 | 8,691,460 | 9,870,219 | |
| Q4 2024 | — | 759 | 0 | 759 | -759 | |||